| Genpharmasec Limited confirmed to the BSE that there was no deviation or variation in the use of proceeds from its rights issue, announced on February 21, 2024, which raised Rs 4,845.05 lakh, according to a regulatory filing on August 11, 2026. The company’s Audit Committee reviewed the statement, which detailed the utilization of funds for acquiring equity shares from existing shareholders of Derren Healthcare Private Limited, repaying borrowings, financing working capital, meeting general corporate purposes, and covering issue expenses. |